Quotables
"The horse is here to stay, the automobile is only a novelty - fad."
President of Michigan Savings Bank ; 1903
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7358248 | Substituted amino carboxylic acids Disclosed are compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of... | 04/15/2008 |
| 7291615 | Cyclic derivatives as modulators of chemokine receptor activity The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and ... | 11/06/2007 |
| 7265110 | Tetrahydropyran derivatives and their use as therapeutic agents The present invention relates compounds of the formula (I); wherein R1, R2, R3, R4, R5, R6, R7, R8, and R10 represent a variety of substituents; A represents NR9 ... | 09/04/2007 |
| 7241759 | Benzo[1,2,5]thiadiazole compounds Certain amidophenyl-sulfanylamino-benzo[1,2,5]thiadiazole compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases. ... | 07/10/2007 |
| 7226896 | Organic emulsion-breaking formula and its use in treating well bores drilled in oil-base mud An organic based emulsion-breaking formulation for use in treating well bores drilled in oil-bearing mud that is not eco-toxic and is optimally compatible with formation fluids comprises: as the emulsion-breaking agent, at least on... | 06/05/2007 |
| 7176330 | Fluorescent group-containing carbodiimide compound precursor, fluorescent group-containing carbodiimide compound and methods for producing them A novel fluorescent group-containing carbodiimide compound having at least one group selected from a carboxyl group, a sulfo group, a phosphono group and a phospho group which have substitution of an alkali metal, an alkaline earth metal or a basic group containing ... | 02/13/2007 |
| 7099146 | Electrolyte for electrochemical capacitor and electrochemical capacitor containing the same The present invention is to provide an electrolyte with which the withstand voltage and capacitor capacity can be prevented from lowering, and an electrochemical capacitor containing the same. | 08/29/2006 |
| 7045521 | Cyclic derivatives as modulators of chemokine receptor activity The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and ... | 05/16/2006 |
| 7037953 | Radiation curable aqueous compositions A method for producing a solvent resistant, low-extractable, film from an actinic radiation curable homogenous aqueous composition containing a water soluble compound, having at least one alpha, beta-ethylenically unsaturated radiation polymerizable double bond, and... | 05/02/2006 |
| 6908918 | Antitumor agents The present invention provides compounds of general formula I or II: wherein R1, R2, R3, R4, R5, R6, and R7 have any of the values defined in... | 06/21/2005 |
| 6780858 | Antibacterial agents Hydroxyamidines and related compounds are provided which are suitable as antibacterial agents. ... | 08/24/2004 |
| 6768024 | Triamine derivative melanocortin receptor ligands and methods of using same The invention provides triamine derivative melanocortin receptor ligands of the formula: wherein R1 to R8 and n have the meanings provided herein. The invention further provides methods of using the... | 07/27/2004 |
| 6734177 | Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors The present invention relates to certain salts of discodermolide acid, pharmaceutical compositions containing said salts, the use of said salts in treating tumors and to a process for making said salts. ... | 05/11/2004 |
| 6706712 | Cyclic derivatives as modulators of chemokine receptor activity The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma. | 03/16/2004 |
| 6656946 | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases Compounds of the formula ##STR1## having an inhibitory effect on signal transduction mediated by tyrosine kinases and their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and airways, and the preparation there... | 12/02/2003 |
| 6653305 | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them A compound of formula (I) ##STR1## wherein: Ra is a benzyl or 1-phenylethyl group or a phenyl group substituted by the groups R1 and R2, wherein: R1 is a hydrogen, fluorine, chlorine, or bromine atom, or a me... | 11/25/2003 |
| 6635761 | Catalyst and method for trimerization of isocyanates This invention relates to the use as catalyst for the cyclotrimerization reaction of isocyanates of a hydrogencarbonate of a cation which either as it is or in the form complexed with a complexing agent has an average molecular or ionic radius of more tha... | 10/21/2003 |
| 6599901 | Pyridone substituted benzothiazole derivatives The present invention relates to compounds of the formula ##STR1## wherein R is as defined herewithin. The compounds of formula I have a good affinity to the A2A receptor and therefore they may be used in the control or prevention of illnesses ... | 07/29/2003 |
| 6593345 | Naphthyl compounds, intermediates, compositions, and methods of use The instant invention provides novel substituted naphthyl compounds, intermediates, compositions, pharmaceutical formulations, and methods of use.... | 07/15/2003 |
| 6531472 | Tetralone derivatives The present invention provides compounds of formula I ##STR1## and pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5, X and Y have the meanings defined in the specification. The compounds have histone deacetylase (HDAC) inhibitory activity whi... | 03/11/2003 |
| 6492514 | Bifunctional photoinitiators suitable for photopolymerization and photopolymerizable systems containing the same The present invention relates to compounds of general formula (I) ##STR1## wherein X1 and X2 are different form each other and have the meanings reported in the following description Y is a simple bond, C1 -C12 linea... | 12/10/2002 |
| 6455735 | Process for the preparation of amine oxides The present invention provides a process for the preparation of high quality amine oxide by reacting a tertiary or secondary amine with hydrogen peroxide as an oxidant in presence of a recyclable heterogeneous layered double hydroxide exchanged with one o... | 09/24/2002 |
| 6448247 | Method for treating an inflammatory disease Compounds of the formula ##STR1## and quaternary ammonium ions thereof, wherein R1 and R2 are the same or different and are carbocyclic aryl or aromatic heterocyclic; A is methylene, carbonyl or sulfonyl; B is a single bond, C1 | 09/10/2002 |
| 6444662 | Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease Described are salts of hyperforin and adhyperforin of formula I [A- ]m [B]p+ (I) wherein m is an integer from 1 to 3, p is equal to m and gives the total number of positive charges of the residue [B], [A- ] is an anion o... | 09/03/2002 |
| 6403826 | Corrosion-inhibiting coating composition for metals A description is given of compounds of the formula ##STR1## in which the general symbols are as defined in claim 1, and of their zirconium, bismuth and calcium salts, and of the salts with the compounds of the formula II ##STR2## in which the general... | 06/11/2002 |
| 6391874 | Fused heterocyclic compounds as protein tyrosine kinase inhibitors Substituted heteroaromatic compounds of formula (I) and in particular substituted quinolines and quinazolines, are protein tyrosine kinase inhibitors. The compounds are described as are methods for their preparation, pharmaceutical compositions including ... | 05/21/2002 |
| 6323367 | Process for the preparation of amine oxides A process for the preparation of high quality amine oxides by reacting a tertiary or secondary amine with hydrogen peroxide as an oxidant in the presence of a recyclable heterogeneous layered double hydroxide exchanged with one of the anions of transition... | 11/27/2001 |
| 6197769 | Indazole amide compounds as serotoninergic agents A compound having general formula (I) wherein R1, R2, R'3, R4, and R6 have the meanings stated in the description, acid addition salts thereof with pharmaceutically acceptable organic and inorganic ac... | 03/06/2001 |
| 6197767 | Arglabin compounds and therapeutic uses thereof The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.... | 03/06/2001 |
| 6194413 | Hemoregulatory compounds The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.... | 02/27/2001 |
| 6159967 | Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use Compounds of the formula and quaternary ammonium ions thereof, wherein R1 and R2 are the same or different and are carbocyclic aryl or aromatic heterocyclic; A is methylene, carbonyl or sulfonyl; B is a single bond, C1 -C | 12/12/2000 |
| 6150527 | Synthetic multimerizing agents New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formula M-L-Q where M is a synthetic ligand for an FKBP protein... | 11/21/2000 |
| 6136803 | Antidepressants The present invention provides novel compounds such as certain aryloxy indanamines which are useful as anti-depressants and as inhibitors of synaptic norepinephrine and serotonin uptake. The present invention also provides an improvement in the treatment ... | 10/24/2000 |
| 6133456 | Synthetic multimerizing agents New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formula M1 --L--M2 where M1 and M2 are independently moieties... | 10/17/2000 |
| 6130331 | Chemical synthesis of a chiral 1,4-oxazin-2-one The present invention relates to a process for the preparation of substantially pure N-((S)-(-)--methylbenzyl)-3-(S)-(4-fluorophenyl)-1,4-oxazin-2-one hydrochloride, which comprises selectively crystallising the (S,S)-diastereomer as the hydro... | 10/10/2000 |
| 6017935 | 7-sulfur substituted paclitaxels The present invention relates to novel taxane derivatives wherein, the taxol ring is substituted by sulfur groups on the C-7, their use as antitumor agents and pharmaceutical formulations.... | 01/25/2000 |
| 6013795 | Alpha-branched fluoroalkylcarbonyl fluorides and their derivatives Briefly, in one aspect, the present invention provides compositions of open-chain, -branched fluoroalkylcarbonyl fluorides, and derivatives thereof.... | 01/11/2000 |
| 5990170 | Therapeutic use of mono and bicarboxylic acid amides active at the peripheral cannabinoid receptor The following description concerns a therapeutic method for the treatment of diseases connected with the modulation of the cannabinoid peripheral receptor, comprising administering amidic derivatives of mono and bicarboxylic acids with aminoalcohols or ar... | 11/23/1999 |
| 5980619 | Corrosion-inhibiting coating composition for metals A description is given of compounds of the formula ##STR1## in which the general symbols are as defined in claim 1, and of their zirconium, bismuth and calcium salts, and of the salts with the compounds of the formula II ##STR2## in which t... | 11/09/1999 |
| 5854237 | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists Tricyclic diazepines of the formula: ##STR1## wherein A, B, D, E, F, Y and Z are defined in the specification which compounds have vasopressin and oxytocin antagonist activity.... | 12/29/1998 |
